456. Wade O.L. Adverse reactions to drugs / O.L. Wade and L. Beeley. -
2nd ed., London, 1976.
457. Wallace R.J. Comparison of the in vitro activity of levofloxacin and
ciproiloxacin against the pathogenic rapidly growing mycobacteria / R.J. Wallace,
B.A. Braun-Elliott, C.J. Crist et al. // 42th Intersci. Conf. Antimicrob. Ag.
Chemother. - Toronto, 2000. - Abstracts, № 2104.
458. Walubo A. Oxidative stress during antituberculous therapy in young
and elderly patients / A. Walubo, P J . Smith, P.I. Folb // Biomed. Environ. Sci. -
1 9 9 5 , - Vol. 8, № 2 . - P . 106-113.
459. Williams A.J. Automated analysis of mitochondrial enzymes in
cultured skin fibriblasts / A.J. Williams, J, Coacley et al. // Anal. Biochem. - 1998,
Jun 1, - Vol. 259, № 2 . - P . 176-180.
460. Wise R. Pharmacokinetics and pharmacjdynamics of fluoroquinolones /
R. Wise, D. Honeybaume // Eur. Respir. J. - 1999. - Vol. 14, № 1. - P. 221-229.
461. Woo J. Correlation between steady-state plasma concentration of
antituberculous drugs and age, inclusion of rifampicin in the treatment regimen,
adverse drug reactions and othe clinical parameters / J. Woo, C. Chan, R. Chan et
al. // J. Med. - 1995. - Vol. 26, № 5-6. - P. 279- 294.
462. Yamanaka K. Characteristics of the medical status and living
conditions of the homeless registered as tuberculosis patients in Nagoya City / K.
Yamanaka, T. Akashi, M. Miyao // Kekkaku. - 1999. - Vol. 74, № 2. - P. 99-105.
464. Yokoyama A. Heart rate variability, arrhythmia and magnesium in
hemodialysis patients / A. Yokoyama, K. Kikuchi, Y. Kawamura // Clin. Calcium.
- 2005. - Vol. 15. - P. 226-232.
465. Zullich B. Amikacin and kanamycin: vergleichende tierexperimentalle
untersuchungen zur nefrotoxizitat / B. Zullich, K. Sack // Arzneimittelforschung. -
1 9 7 8 . - Vol. 28, № 2 . - P 271-278.
405
